Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $9.60 in the prior trading day, Travere Therapeutics Inc (NASDAQ: TVTX) closed at $10.05, up 4.69%. In other words, the price has increased by $4.69 from its previous closing price. On the day, 1.94 million shares were traded. TVTX stock price reached its highest trading level at $10.105 during the session, while it also had its lowest trading level at $9.34.
Ratios:
Our goal is to gain a better understanding of TVTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 26.62 whereas as Long-Term Debt/Eq ratio is at 26.27.
On December 05, 2023, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7 to $10.
On November 20, 2023, Citigroup started tracking the stock assigning a Neutral rating and target price of $7.Citigroup initiated its Neutral rating on November 20, 2023, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 11 ’24 when Cline Christopher R. sold 54 shares for $6.74 per share. The transaction valued at 364 led to the insider holds 70,849 shares of the business.
Dube Eric M sold 19,122 shares of TVTX for $166,435 on Feb 01 ’24. The CHIEF EXECUTIVE OFFICER now owns 350,600 shares after completing the transaction at $8.70 per share. On Feb 01 ’24, another insider, ROTE WILLIAM E., who serves as the SENIOR VICE PRESIDENT, R&D of the company, sold 4,764 shares for $8.71 each. As a result, the insider received 41,495 and left with 80,720 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 768739648 and an Enterprise Value of 812148224. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.33 while its Price-to-Book (P/B) ratio in mrq is 50.73. Its current Enterprise Value per Revenue stands at 4.572 whereas that against EBITDA is -2.953.
Stock Price History:
Over the past 52 weeks, TVTX has reached a high of $15.04, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 11.08%, while the 200-Day Moving Average is calculated to be 26.76%.
Shares Statistics:
The stock has traded on average 1.07M shares per day over the past 3-months and 755070 shares per day over the last 10 days, according to various share statistics. A total of 76.49M shares are outstanding, with a floating share count of 75.74M. Insiders hold about 0.98% of the company’s shares, while institutions hold 117.33% stake in the company. Shares short for TVTX as of 1723680000 were 9295562 with a Short Ratio of 8.70, compared to 1721001600 on 10099233. Therefore, it implies a Short% of Shares Outstanding of 9295562 and a Short% of Float of 13.669999999999998.
